Delivery Order SPE2DB22D2009-SPE2DB24FL9MF
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order with a Firm Fixed Price of $10,434.52 for the supply of DUPIXENT 300 MG/2 ML PEN 2ML medication. The contract, awarded by the Defense Logistics Agency (DLA), has an ultimate completion date of April 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB20D1050|SPE2DB24FH50M) with a ceiling value of $5,084.17. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 9, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $41,935.36 firm fixed-price delivery order placed by the Defense Logistics Agency (DLA). The contract covers the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, with a period of performance through February 15, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $27,100.61 firm fixed-price delivery order is for the supply of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,760.81 firm fixed-price delivery order is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,858.13 and a period of performance through January 31, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract was awarded on January 30, 2024 and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $5,275.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DUPIXENT 200 MG/1.14 ML PEN 1.14ML, a pharmaceutical product, with a completion date of October 30, 2023. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor and healthcare solutions...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The Delivery Order, valued at $28,595.22, is for the procurement of DUPIXENT 200 MG/1.14 ML PEN 1.14ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through December 28, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,799.97 for the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, on April 5, 2022 with an ultimate completion date of April 6, 2022. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $22,405.65 for the supply of Dupixent 300 mg/2 ml pens. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 28, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB24FL9MFDelivery Order
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $16,289.55 and covers the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of May 3, 2024 and is a Firm Fixed Price Delivery Order with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's healthcare needs globally. Additionally, Cencora, Inc. holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 5/2/24 |